Sana Biotechnology Stock Quote SANA - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

4.25

Bid

4.15

Ask

4.80

Volume

0.00 Day's Range 0.00

2.745 52 Week Range 12.00

Market Cap

945.48M

Previous Close

4.25

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,525,864

Shares Outstanding

222,465,934

Dividend Yield

PE Ratio

-3.34

Earnings Per Share (EPS)

-1.27

Revenue

Net Profit

-283.26M

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring tec... Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring technology, organizing and staffing the Company, business planning, establishing the company's intellectual property portfolio, raising capital, and providing general and administrative support for these operations. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.sana.com

Headquarters

Wilmington, Delaware, USA

Founded

Sana Biotechnology Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SANA. The last closing price for Sana Biotechnology was $4.25. Over the last year, Sana Biotechnology shares have traded in a share price range of $ 2.745 to $ 12.00.

Sana Biotechnology currently has 222,465,934 shares outstanding. The market capitalization of Sana Biotechnology is $945.48 million. Sana Biotechnology has a price to earnings ratio (PE ratio) of -3.34.

Form 8-K - Current report

Sana Biotechnology to Present at September 2024 Investor Conferences

SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will...

Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer

SEATTLE, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.26	-5.76496674058	4.51	4.73	4.1501	1717928	4.34443792	CS
4	-1.66	-28.0879864636	5.91	6.34	4.135	1379807	4.96622322	CS
12	-1.2	-22.0183486239	5.45	7.4	4.135	1525864	5.4376405	CS
26	-4.94	-53.7540805223	9.19	10.5	4.135	1682095	6.75598116	CS
52	0.27	6.78391959799	3.98	12	2.745	2075369	6.38707268	CS
156	-18.17	-81.0437109723	22.42	23.5	2.745	1441429	6.70728691	CS
260	-33.65	-88.7862796834	37.9	44.6	2.745	1310549	8.44082835	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUKKNukkleus Inc	$ 0.3586 (68.75%)	14.54M
SOXMTradr 2X Long SOXX Monthly ETF	$ 36.96 (58.98%)	45
NVVENuvve Holding Corporation	$ 5.89 (50.26%)	1.29M
LGCBLinkage Global Inc	$ 0.5866 (40.23%)	10.65M
LGHLWLion Group Holding Ltd	$ 0.008 (33.33%)	12
PRFXPainReform Ltd	$ 0.5856 (-24.06%)	17.05k
ZJYLJin Medical International Ltd	$ 3.20 (-21.57%)	23.18k
ADTXAditxt Inc	$ 0.3046 (-20.39%)	65.18k
SMXTSolarMax Technology Inc	$ 0.7029 (-19.75%)	200
CJETChijet Motor Company Inc	$ 2.28 (-18.57%)	793
NUKKNukkleus Inc	$ 0.3586 (68.75%)	14.54M
LGCBLinkage Global Inc	$ 0.581 (38.90%)	10.65M
MAXNMaxeon Solar Technologies Ltd	$ 0.0788 (-13.88%)	3.33M
GSIWGarden Stage Ltd	$ 1.64 (22.39%)	3.12M
INTCIntel Corporation	$ 22.48 (2.93%)	1.96M